ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Outcome measures"

  • Abstract Number: 2223 • 2015 ACR/ARHP Annual Meeting

    Improving Clinical Decisions for Rheumatoid Arthritis Management Using Online Medical Simulations

    Nimish Mehta1, Keith Johnson2, Douglas Blevins3 and Martin Warters3, 1Medscape, LLC, New York, NY, 2Medscape Education, New York, NY, 3Medscape, LLC, Durham, NC

    Background/Purpose: In many patients with rheumatoid arthritis (RA), the disease is not adequately controlled, and only a minority of patients attain the goal of consistent…
  • Abstract Number: 2224 • 2015 ACR/ARHP Annual Meeting

    Tailored, Online Education on Comparative Effectiveness Studies in Rheumatoid Arthritis: Success in Improving Knowledge and Clinical Decisions

    Nimish Mehta, Emilie McCardell and Kathleen Geissel, Medscape, LLC, New York, NY

    Background/Purpose: Analysis of past educational activities on comparative effectiveness studies in RA identified different educational needs for varying segments of rheumatologists – from interpretation of…
  • Abstract Number: 50 • 2015 ACR/ARHP Annual Meeting

    Characteristics and Outcomes Associated with Early Corticosteroid Use in a Large Multicenter Canadian RA Cohort

    Kathleen Andersen1, Daming Lin2, Susan J. Bartlett3,4, Gilles Boire5, Boulos Haraoui6, Carol Hitchon7, Shahin Jamal8, Edward C. Keystone9, Janet E. Pope10, Diane Tin11, J Carter Thorne12, VP Bykerk13,14 and CATCH Investigators, 1Hospital for Special Surgery, New York, NY, 2Rheumatology, Mount Sinai Hospital, University of Toronto, Toronto, ON, Canada, 3Division of Rheumatology, Johns Hopkins School of Medicine, Baltimore, MD, 4Medicine , Divisions of Clinical Epidemiology, Rheumatology, Respirology, McGill University, Montreal, QC, Canada, 5Department of Medicine/Division of Rheumatology, Université de Sherbrooke, Sherbrooke, QC, Canada, 6Institut de Rhumatologie, Montreal, QC, Canada, 7Department of Rheumatology, University of Manitoba, Winnipeg, MB, Canada, 8Vancouver Coastal Health, Vancouver, BC, Canada, 9Mount Sinai Hospital, University of Toronto, Toronto, ON, Canada, 10University of Western Ontario, London, ON, Canada, 11The Arthritis Program, Southlake Regional Health Centre, Newmarket, ON, Canada, 12University of Toronto, Toronto, ON, Canada, 13Rheumatology, Hospital for Special Surgery, New York, NY, 14Medicine, Mount Sinai Hospital/University of Toronto, Toronto, ON, Canada

    Background/Purpose: Synthetic glucocorticoids (steroids) are commonly used in RA to rapidly inhibit pro-inflammatory cytokines. They are frequently used as "bridge therapy", quickly dampening down the…
  • Abstract Number: 2330 • 2015 ACR/ARHP Annual Meeting

    The Turkish  Validity and Reliability of  the Systemic Lupus Erythematosus Quality of Life Questionnaire (L-QoL)

    M Tuncay Duruoz1, Canan Sanal Top2, Ilhan Sezer3, Figen Yılmaz4, Cagri Ünal2, Hatica Sule Baklacioglu5, Firat Ulutatar6 and Pamir Atagunduz7, 1Dept of PM&R, Rheumatology Clinic, Marmara University Medical School, Istanbul, Turkey, 2PM&R, Marmara University Medical School, Istanbul, Turkey, 3Rheumatology, Physical Medicine and Rheabilitation, Antalya Education and Research Hospital, Antalya, Turkey, 4PM&R, Sisli Hamidiye Etfal Training and Research Hospital, Istanbul, Turkey, 5Rheumatology, Marmara University Medical School, Istanbul, Turkey, 6Physical Medicine and Rehabilitation Department, Marmara University Medical School, Istanbul, Turkey, 7Department of Rheumatology, Marmara University Faculty of Medicine, Istanbul, Turkey

    Background/Purpose: The Systemic Lupus Erythematosus Quality of Life Questionnaire (L-QoL) is a disease-specific measure of needs-based quality of life developed in the United Kingdom (1).…
  • Abstract Number: 158 • 2015 ACR/ARHP Annual Meeting

    Ultrasound Score of Dominant Hand in Patients with Rheumatoid Arthritis Correlates with DAS28CRP, CDAI and SDAI but Not RAPID-3

    Allen P. Anandarajah1, Bethany Marston2, Linda Grinnell-Merrick2 and Ralf G. Thiele3, 1Dept of Rheumatology, Univ of Rochester Medical Ctr, Rochester, NY, 2Rheumatology, University of Rochester Medical Center, Rochester, NY, 3University of Rochester Medical Center, Rochester, NY

    Background/Purpose: Musculoskeletal ultrasound (MUS) allows for direct visualization of diverse pathologic features such as cortical bone erosions, synovial thickening, and synovial vascularity in the joints…
  • Abstract Number: 2539 • 2015 ACR/ARHP Annual Meeting

    The Validity and Reliability of Turkish Version of the Jenkins Sleep Scale in Rheumatoid Arthritis

    M Tuncay Duruoz1, Cagri Ünal2, Firat Ulutatar3, Canan Sanal Top2 and Osman Hakan Gunduz4, 1Dept of PM&R, Rheumatology Clinic, Marmara University Medical School, Istanbul, Turkey, 2PM&R, Marmara University Medical School, Istanbul, Turkey, 3Physical Medicine and Rehabilitation Department, Marmara University Medical School, Istanbul, Turkey, 4Physical Medicine and Rehabilitation, Marmara University School of Medicine, Istanbul, Turkey

    Background/Purpose:  The Jenkins Sleep Scale has 4 questions to assess the estimation of sleep problems in clinical research. It was developed in USA (1).   Aim: To…
  • Abstract Number: 190 • 2015 ACR/ARHP Annual Meeting

    Ultrasound Imaging with Elastography for the Medical Treatment of Dupuytren’s Contracture

    Paul John DeMarco1, Alan K. Matsumoto1, Nicole Thomas2, Megan Bishop1, Andrew Gregory DeMarco3, Guada Respicio1, Ashley Beall1, Robert Rosenberg1, Theresa Bass-Goldman1 and Herbert S. B. Baraf1, 1The Center for Rheumatology and Bone Research, Wheaton, MD, 2Rheumatology, Georgetown University Hospital, Washington DC, DC, 3Duquesne University, Pittsburgh, PA

    Background/Purpose:  Dupuytren’s contracture is a rheumatic disease characterized by an fibrotic reaction in the palmar aponeurosis, resulting in disability.  Medical treatment with up to 3…
  • Abstract Number: 2596 • 2015 ACR/ARHP Annual Meeting

    Less Musculoskeletal Ultrasound Power Doppler Activity Seen in Obese Rheumatoid Arthritis

    Erin Bauer1, Ami Ben-Artzi2, Erin Duffy1, David Elashoff1, Cesar Olmos3 and Veena K. Ranganath3, 1Medicine, David Geffen School of Medicine, Los Angeles, CA, 2David Geffen School of Medicine, Los Angeles, CA, 3Medicine, Division of Rheumatology, David Geffen School of Medicine, Los Angeles, CA

    Background/Purpose:  Studies report that obese and overweight patients with rheumatoid arthritis (RA) are less likely to attain remission and more likely to have limited therapeutic…
  • Abstract Number: 438 • 2015 ACR/ARHP Annual Meeting

    Comparison of the Stanford and Indian Health Assessment Questionnaires for Disability Outcomes in a Phase 3, Randomized, Double-Blind, Active Comparator Study of Infliximab and Biosimilar Infliximab BOW15 in Rheumatoid Arthritis

    Arvind Chopra1, Manjit Saluja2, Alastair Knight3, Lucy Shneyer4, Cheryl Lassen5, Michael Wyand6 and Jonathan Kay7, 1Rheumatology, Centre for Rheumatic Diseases, Pune 411001, India, 2Centre for Rheumatic Diseases, Pune 411001, India, 3Data Management, Evicom Ltd, Twickenham, United Kingdom, 4Shneyer Statistics, Denville, NJ, 5Epirus Biopharmaceuticals, Zug, Switzerland, 6Epirus Biopharmaceuticals, Boston, MA, 7University of Massachussets Medical School, Worcester, MA

    Background/Purpose: The Stanford Health Assessment Questionnaire (HAQ) includes several questions that are more relevant to rheumatoid arthritis (RA) patients in Western countries than to those…
  • Abstract Number: 2646 • 2015 ACR/ARHP Annual Meeting

    Different Wording of the Patient Global Assessment Scale Leads to Different Rating of Disease Activity

    Helga Radner1, Paul Studenic2, Stanley B. Cohen3, N Shadick4, C Iannaccone5, Elisabeth Lie6, Maria Dahl Mjaavatten6, Meredith Leigh Cohen3, Josef S. Smolen7 and Daniel Aletaha8, 1Department of Internal Medicine III; Division of Rheumatology, Medical University of Vienna, Vienna, Austria, 2Department of Internal Medicine 3, Division of Rheumatology, Medical University Vienna, Vienna, Austria, 3Metroplex Clinical Research Center, Dallas, TX, 4Division of Rheumatology, Immunology & Allergy, Brigham and Women's Hosp, Boston, MA, 5Division of Rheumatology, Immunology and Allergy, Brigham and Women’s Hospital, Boston, MA, 6Dept. of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway, 7Dept of Medicine 3, Division of Rheumatology, Medical Univ Vienna, Vienna, Austria, 8Rheumatology, Medical University Vienna, Vienna, Austria

    Background/Purpose: The patient global assessment of disease activity (PtGA) is a key variable in assessing RA disease activity and remission (REM). Typically assessed on a…
  • Abstract Number: 649 • 2015 ACR/ARHP Annual Meeting

    Measures of Health-Related Quality of Life in Psoriatic Arthritis: Are They Sensitive to Both Joint and Skin Aspects?

    Mwidimi Ndosi1, Ming-Anne Hsu2, J. Cappelleri3, Amit Chhabra4, Heather Jones5 and Philip S. Helliwell6, 1School of Healthcare, University of Leeds, Leeds, United Kingdom, 2445 Eastern Point Road, Pfizer Inc, Groton, CT, 3Statistics, Pfizer Inc, New London, CT, 4Pfizer Inc, Collegeville, PA, 5Inflammation Global Medical Affairs, Pfizer, Collegeville, PA, 6Section of Musculoskeletal Disease, University of Leeds, Leeds, United Kingdom

    Background/Purpose: Psoriatic Arthritis Quality of Life (PsAQol), Ankylosing Spondylitis Quality of Life (ASQoL), and Dermatology Life Quality Index (DLQI) are tools that assess different aspects of health-related…
  • Abstract Number: 2666 • 2015 ACR/ARHP Annual Meeting

    Trajectories of EQ-5D in RA Patients Treated with Biologics Using the IORRA Cohort

    Daisuke Hoshi, Eiichi Tanaka, Eisuke Inoue, Yoko Shimizu, Naoki Sugimoto, Kumi Shidara, Ayako Nakajima, Shigeki Momohara, Atsuo Taniguchi and Hisashi Yamanaka, Institute of Rheumatology, Tokyo Women’s Medical University, Tokyo, Japan

    Background/Purpose: Patient-reported outcomes are recognized as important for evaluating the disease status of rheumatoid arthritis (RA). The EuroQol 5-dimensional descriptive system (EQ-5D) has been used…
  • Abstract Number: 2518 • 2014 ACR/ARHP Annual Meeting

    What Is the Level of Agreement Between Disease Activity Indices and Response Criteria Among Rheumatoid Arthritis Patients Treated with TNF Inhibitors?

    Edward C. Keystone1, Philip Baer2, J. Antonio Avina-Zubieta3, Anna Jaroszynska4, Jude Rodrigues5, Regan Arendse6, Dalton Sholter7, Michael Starr8, Ariel Masetto9, John S. Sampalis10, Emmanouil Rampakakis10, Francois Nantel11, May Shawi11, Allen J Lehman12 and Susan Otawa12, 1Medicine, University of Toronto, Toronto, ON, Canada, 2Private Practice, Scarborough, ON, Canada, 3Rheumatology, Arthritis Research Centre of Canada, Richmond, BC, Canada, 4Private Practice, Burlington, ON, Canada, 5Clinical Research and Arthritis Centre, Windsor, ON, Canada, 6University of Saskatchewan, Saskatoon, SK, Canada, 7University of Alberta, Edmonton, AB, Canada, 8Rheumatology, McGill University Health Centre, Montreal, QC, Canada, 9Rheumatology, CHUS, Fleurimont, QC, Canada, 10JSS Medical Research, Montreal, QC, Canada, 11Janssen Inc., Toronto, ON, Canada, 12Medical Affairs, Janssen Inc., Toronto, ON, Canada

    Background/Purpose: Several standardized response criteria and disease activity indices are used to assess treatment efficacy in rheumatoid arthritis (RA). These measures comprise different types and…
  • Abstract Number: 2335 • 2014 ACR/ARHP Annual Meeting

    Reliability and Validity of the Arthritis Helplessness Index in Systemic Sclerosis

    Shadi Gholizadeh1, Sarah D. Mills2, Rina S. Fox2, Philip J. Clements3, Suzanne Kafaja4, Vanessa L. Malcarne5, Daniel E. Furst6 and Dinesh Khanna7, 1Psychology, SDSU/UCSD Joint Doctoral Program in Clinical Psychology, San Diego, CA, 2SDSU/UCSD Joint Doctoral Program in Clinical Psychology, San Diego, CA, 3University of California, Los Angeles, Department of Medicine, Los Angeles, CA, 4Medicine, University of California, Los Angeles, Department of Medicine, Los Angeles, CA, 5Psychology, SDSU/UCSD Joint Doctoral Program in Clinical Psychology; Department of Psychology, San Diego State University, San Diego, CA, 6Medicine/ Rheumatology, University of California, Los Angeles, Department of Medicine, Los Angeles, CA, 7University of Michigan Health System, Ann Arbor, MI

    Background/Purpose: The unpredictable and uncontrollable course of rheumatic diseases has made them an interesting area of study in the learned helplessness and health outcomes literature.…
  • Abstract Number: 1987 • 2014 ACR/ARHP Annual Meeting

    Simulation in Continuing Education: Improving Evidence-Based Decisions for Rheumatoid Arthritis Management

    Nimish Mehta1, Martin Warters2 and Douglas Blevins2, 1Medscape, LLC, New York, NY, 2Therasim, Durham, NC

    Background/Purpose In many patients with rheumatoid arthritis (RA), the disease is not adequately controlled, and only a minority of patients attain the goal of consistent…
  • « Previous Page
  • 1
  • …
  • 42
  • 43
  • 44
  • 45
  • 46
  • …
  • 49
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

ACR Abstract Embargo Policy

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. Academic institutions, private organizations and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part a scientific presentation or presentation of additional new information that will be available at the time of the meeting) is under embargo until Saturday, November 11, 2023.

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying financial and other sponsors about this policy. If you have questions about the abstract embargo policy, please contact the public relations department at [email protected].

Copyright Policy

View ACR Policies.

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology